This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: A Global Overview and Recent Trends. Eur Urol 2017; 71: 96-108. doi: 10.1016/j.eururo.2016.06.010AntoniSFerlayJSoerjomataramIZnaorAJemalABrayFBladder cancer incidence and mortality: A Global Overview and Recent TrendsEur Urol20177196108doi10.1016/j.eururo.2016.06.01027370177Open DOISearch in Google Scholar
Mariappan P, Fineron P, O’Donnell M, Gailer RM, Watson DJ, Smith G, et al. Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up. World J Urol 2020; [Ahead of print]. doi: 10.1007/s00345-020-03180-5MariappanPFineronPO’DonnellMGailerRMWatsonDJSmithGet alCombining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-upWorld J Urol2020Ahead of printdoi10.1007/s00345-020-03180-5791037532266509Open DOISearch in Google Scholar
Babjuk M, Burger M, Compérat E, Gontero P, Mostafid AH, Palou J, et al. EAU Guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) 2020. European Association of Urology Guidelines 2020 Edition. Presented at the EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2020.BabjukMBurgerMCompératEGonteroPMostafidAHPalouJet alEAU Guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) 2020European Association of Urology Guidelines 2020 EditionPresented at the EAU Annual Congress Amsterdam 2020Arnhem, The NetherlandsEuropean Association of Urology Guidelines Office2020Search in Google Scholar
Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol 2015; 33: 66.e25-31. doi: 10.1016/j. urolonc.2014.06.008YafiFABrimoFSteinbergJAprikianAGTanguaySKassoufWProspective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancerUrol Oncol20153366e25-31doi10.1016/j.urolonc.2014.06.00825037483Open DOISearch in Google Scholar
Trinh TW, Glazer DI, Sadow CA, Sahni VA, Geller NL, Silverman SG. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results. Abdom Radiol 2018; 43: 663-71. doi: 10.1007/s00261-017-1249-6TrinhTWGlazerDISadowCASahniVAGellerNLSilvermanSGBladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative resultsAbdom Radiol20184366371doi10.1007/s00261-017-1249-628677000Open DOISearch in Google Scholar
Kim J, Kim WT, Kim WJ. Advances in urinary biomarker discovery in urological research. Investig Clin Urol 2020; 61: S8-22. doi: 10.4111/icu.2020.61. S1.S8.KimJKimWTKimWJAdvances in urinary biomarker discovery in urological researchInvestig Clin Urol202061S822doi10.4111/icu.2020.61S1.S8Open DOISearch in Google Scholar
Pichler R, Fritz J, Tulchiner G, Klinglmair G, Soleiman A, Horninger W, et al. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance. BJU Int 2018; 121: 29-37. doi: 10.1111/bju.14019PichlerRFritzJTulchinerGKlinglmairGSoleimanAHorningerWet alIncreased accuracy of a novel mRNA-based urine test for bladder cancer surveillanceBJU Int20181212937doi10.1111/bju.1401928941000Open DOISearch in Google Scholar
Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, et al. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2017; 71: 447-61. doi: 10.1016/j.eururo.2016.05.041BabjukMBohleABurgerMCapounOCohenDComperatEMet alEAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016Eur Urol20177144761doi10.1016/j.eururo.2016.05.04127324428Open DOISearch in Google Scholar
Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, et al. The Paris System for reporting urinary cytology: the quest to develop a standardized terminology. Adv Anat Pathol 2016; 23: 193-201. doi: 10.1097/PAP.0000000000000118BarkanGAWojcikEMNayarRSavic-PrinceSQuekMLKurtyczDFet alThe Paris System for reporting urinary cytology: the quest to develop a standardized terminologyAdv Anat Pathol201623193201doi10.1097/PAP.000000000000011827233050Open DOISearch in Google Scholar
Wallace E, Higuchi R, Satya M, McCann L, Sin MLY, Bridge JA, et al. Development of a 90-minute integrated noninvasive urinary assay for bladder cancer detection. J Urol 2018; 199: 655-62. doi: 10.1016/j.juro.2017.09.141WallaceEHiguchiRSatyaMMcCannLSinMLYBridgeJAet alDevelopment of a 90-minute integrated noninvasive urinary assay for bladder cancer detectionJ Urol201819965562doi10.1016/j.juro.2017.09.14129061538Open DOISearch in Google Scholar
Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Eighth edition. Chichester, West Sussex, UK; Hoboken, NY: John Wiley & Sons, Inc.; 2017.BrierleyJGospodarowiczMKWittekindCTNM classification of malignant tumoursEighth editionChichester, West Sussex, UK; Hoboken, NYJohn Wiley & Sons, Inc201710.1002/9780471420194.tnmc26.pub3Search in Google Scholar
Moch H, Reuter VE, Humphrey PA, Ulbright TM. WHO classification of tumours of the urinary system and male genital organs. International Agency for Research on Cancer; 2016.MochHReuterVEHumphreyPAUlbrightTMWHO classification of tumours of the urinary system and male genital organsInternational Agency for Research on Cancer201610.1016/j.eururo.2016.02.029Search in Google Scholar
Hentschel AE, van Rhijn BWG, Brundl J, Comperat EM, Plass K, Rodriguez O, et al. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? Urol Oncol 2020; 38: 440-8. doi: 10.1016/j.urolonc.2019.10.002HentschelAEvan RhijnBWGBrundlJComperatEMPlassKRodriguezOet alPapillary urothelial neoplasm of low malignant potential (PUN-LMP): still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Urol Oncol2020384408doi10.1016/j.urolonc.2019.10.002Open DOISearch in Google Scholar
The Paris System for reporting urinary cytology. Rosenthal DL, Wojcik EM, Kurtycz DFI, editors. New York, NY: Springer Science and Business Media; 2015.The Paris System for reporting urinary cytologyRosenthalDLWojcikEMKurtyczDFIeditorsNew York, NYSpringer Science and Business Media2015Search in Google Scholar
Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 2002; 41: 284-9. doi: 10.1016/s0302-2838(02)00006-4RaitanenMPAineRRintalaEKallioJRajalaPJuuselaHet alDifferences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysisEur Urol2002412849doi10.1016/s0302-2838(02)00006-4Open DOISearch in Google Scholar
Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009; 55: 815-25. doi: 10.1016/j.eururo.2009.01.002StenzlACowanNCDe SantisMJakseGKuczykMAMerseburgerASet alThe updated EAU guidelines on muscle-invasive and metastatic bladder cancerEur Urol20095581525doi10.1016/j.eururo.2009.01.002Open DOISearch in Google Scholar
Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, et al. Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project. World J Urol 2020; 38: 2215-20. doi: 10.1007/s00345-019-03002-3HurleRCasalePSaitaAColomboPElefanteGMLughezzaniGet alClinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) projectWorld J Urol202038221520doi10.1007/s00345-019-03002-3Open DOISearch in Google Scholar
Valenberg F, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, et al. Prospective validation of an mRNA-based urine test for surveillance of patients with bladder cancer. Eur Urol 2019; 75: 853-60. doi: 10.1016/j. eururo.2018.11.055ValenbergFHiarAMWallaceEBridgeJAMayneDJBeqajSet alProspective validation of an mRNA-based urine test for surveillance of patients with bladder cancerEur Urol20197585360doi10.1016/j.eururo.2018.11.055Open DOISearch in Google Scholar
Elia DC, Pycha A, Folchini DM, Mian C, Hanspeter E, Schwienbacher C, et al. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer. J Clin Pathol 2019; 72: 140-4. doi: 10.1136/jclinpath-2018-205393EliaDCPychaAFolchiniDMMianCHanspeterESchwienbacherCet alDiagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancerJ Clin Pathol2019721404doi10.1136/jclinpath-2018-205393Open DOISearch in Google Scholar
Soria F, Droller MJ, Lotan Y, Gontero P, D’Andrea D, Gust KM, et al. An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J Urol 2018; 36: 1981-95. doi: 10.1007/s00345-018-2380-xSoriaFDrollerMJLotanYGonteroPD’AndreaDGustKMet alAn up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancerWorld J Urol201836198195doi10.1007/s00345-018-2380-xOpen DOISearch in Google Scholar
Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 2001; 165: 1124-8. PMID: 11257652HolmangSAndiusPHedelinHWesterKBuschCJohanssonSLStage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidyJ Urol200116511248PMID: 1125765210.1016/S0022-5347(05)66443-9Search in Google Scholar
Gofrit ON, Pode D, Lazar A, Katz R, Shapiro A. Watchful waiting policy in recurrent Ta G1 bladder tumors. Eur Urol 2006; 49: 303-6. doi: 10.1016/j.eururo.2005.12.029GofritONPodeDLazarAKatzRShapiroAWatchful waiting policy in recurrent Ta G1 bladder tumorsEur Urol2006493036doi10.1016/j.eururo.2005.12.02916413659Open DOISearch in Google Scholar
